|1.||Hatzoglou, Maria: 3 articles (05/2009 - 01/2002)|
|2.||Yaman, Ibrahim: 3 articles (05/2009 - 01/2002)|
|3.||Ezatpour, Behrouz: 2 articles (10/2015 - 01/2015)|
|4.||Kheirollahi, Majid: 2 articles (10/2015 - 01/2015)|
|5.||Mohammadi, Mehrdad: 2 articles (10/2015 - 01/2015)|
|6.||Koulivand, Leila: 2 articles (10/2015 - 01/2015)|
|7.||Dufès, Christine: 2 articles (10/2011 - 09/2011)|
|8.||Tetley, Laurence: 2 articles (10/2011 - 09/2011)|
|9.||Blatchford, David R: 2 articles (10/2011 - 09/2011)|
|10.||Aldawsari, Hibah: 2 articles (10/2011 - 09/2011)|
10/01/2011 - "Arg-, Lys- and Leu-bearing PEI polyplexes are therefore highly promising gene delivery systems for cancer therapy."
02/15/1999 - "We infected 28 sheep with BLV and cloned exon 2 of the OLA-DRB1 gene from asymptomatic animals and from animals with lymphoma Sequence analysis revealed that, among 12 healthy sheep without any evidence of tumor, ten (83.3%) carried DRB1 alleles encoding Arg-Lys (RK) at positions beta70/71 as compared with only 6 (37.5%) of the 16 sheep with lymphoma, which suggested that alleles encoding the RK motif might protect against development of tumors after infection by BLV. "
10/01/2011 - "The intravenous administration of Arg-, Lys- and Leu-bearing PEI polyplexes led to a significant increase of gene expression in the tumor, with a β-galactosidase expression amount at least threefold higher than that obtained after treatment with unmodified PEI polyplex. "
10/01/2011 - "Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polyethylenimine polyplex."
09/01/2011 - "In this work we demonstrated that the conjugation of arginine, lysine and leucine to the dendrimer led to an enhanced anti-proliferative activity of the polyplexes, by up to 47-fold for DAB-Lys in T98G cancer cells compared to the unmodified polyplex in vitro. "
05/01/1994 - "In order to evaluate the clinical efficacy of an arginine-lysine-lactose preparation a group of 40 subjects with senile involutional osteoporosis was studied. "
06/01/1994 - "[Experience regarding the use of arginine-lysine-lactose treatment in menopausal osteoporosis]."
05/01/1994 - "[The effects of the carbocalcitonin + arginine-lysine-lactose combination in senile involutional osteoporosis]."
10/01/2004 - "Defects in this heteromeric transporter cause cystinuria, which is also characterized by urinary loss of arginine, lysine, and ornithine. "
10/01/2015 - "Cystinuria is an autosomal inherited disorder of renal reabsorption of cystine, arginine, lysine, and ornithine. "
12/01/1990 - "Cystinuria is an hereditary disorder of renal and intestinal transport characterized by the excessive urinary excretion of cystine, arginine, lysine, and ornithine. "
01/01/2015 - "Cystinuria, one of the first inborn errors of metabolism, is characterized by hyperexcretion of cystine, arginine, lysine, and ornithine into urine. "
09/01/2005 - "Cystinuria is a frequently inherited metabolic disorder in the Czech population (frequency 1/5,600) caused by a defect in the renal transport of cystine and dibasic amino acids (arginine, lysine and ornithine). "
02/15/2007 - "The arginine/lysine transporter, cat-1, is induced during amino acid starvation by transcriptional and post-transcriptional mechanisms. "
02/15/2007 - "A feedback transcriptional mechanism controls the level of the arginine/lysine transporter cat-1 during amino acid starvation."
01/18/2002 - "Here it is shown that translation of the arginine/lysine transporter cat-1 mRNA increases during amino acid starvation of mammalian cells. "
05/01/2009 - "It was previously shown that translation of the mRNA for the arginine/lysine amino acid transporter Cat-1 increases during amino acid starvation via a mechanism that utilizes an IRES in the 5' untranslated region of the Cat-1 mRNA. "
05/01/2009 - "The hnRNA-binding proteins hnRNP L and PTB are required for efficient translation of the Cat-1 arginine/lysine transporter mRNA during amino acid starvation."
05/01/2001 - "Alpha2(CD31 AGG-->AAG, Arg-->Lys) causing non-deletional alpha-thalassemia in a Chinese family with HbH disease."
02/01/2001 - "Among those 15 samples screened for alpha-thalassemia mutation were 10 samples with Hb CS mutation, 2 samples with Hb QS mutation, 2 samples with Hb Westmead mutation, and a previously unreported one, alpha2 CD31 AGG-->AAG(Arg-->Lys), confirmed by DNA sequencing. "
|3.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|9.||Glutamic Acid (Glutamate)